• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的病因发病机制。

Aetio-pathogenesis of breast cancer.

作者信息

Abdulkareem Imran Haruna

机构信息

Department of Trauma and Orthopaedic Surgery, Leeds University Teaching Hospital, Leeds, UK.

出版信息

Niger Med J. 2013 Nov;54(6):371-5. doi: 10.4103/0300-1652.126284.

DOI:10.4103/0300-1652.126284
PMID:24665149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3948957/
Abstract

This is a literature review on the aetiology and pathogenesis of breast cancer, which is the most common cancer worldwide, and the second leading cause of cancer death, especially in Western countries. Several aetiological factors have been implicated in its pathogenesis, and include age, genetics, family history, diet, alcohol, obesity, lifestyle, physical inactivity, as well as endocrine factors. These factors act separately or together in the causation of breast cancer. More recently, triple negative breast cancer has been described in certain categories of patients and is associated with poorer prognosis and earlier recurrence compared with the conventional breast cancer. Therefore, adequate knowledge of these factors is important in identifying high risk groups and individuals, which will help in screening, early detection and follow-up. This will help to decrease the morbidity and mortality from this life-threatening disease.

摘要

这是一篇关于乳腺癌病因和发病机制的文献综述。乳腺癌是全球最常见的癌症,也是癌症死亡的第二大主要原因,尤其在西方国家。其发病机制涉及多个病因学因素,包括年龄、遗传、家族史、饮食、酒精、肥胖、生活方式、缺乏身体活动以及内分泌因素。这些因素在乳腺癌的发生中单独或共同起作用。最近,在某些类型的患者中发现了三阴性乳腺癌,与传统乳腺癌相比,其预后较差且复发较早。因此,充分了解这些因素对于识别高危群体和个体很重要,这将有助于筛查、早期发现和随访。这将有助于降低这种危及生命的疾病的发病率和死亡率。

相似文献

1
Aetio-pathogenesis of breast cancer.乳腺癌的病因发病机制。
Niger Med J. 2013 Nov;54(6):371-5. doi: 10.4103/0300-1652.126284.
2
Triple-negative breast cancer: epidemiological considerations and recommendations.三阴性乳腺癌:流行病学考虑因素和建议。
Ann Oncol. 2012 Aug;23 Suppl 6:vi7-12. doi: 10.1093/annonc/mds187.
3
Responding to the challenges of breast cancer in egypt and other arab countries.应对埃及及其他阿拉伯国家乳腺癌带来的挑战。
J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12.
4
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
5
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
6
Oncology in midlife and beyond.中年及以后的肿瘤学。
Climacteric. 2013 Oct;16(5):522-35. doi: 10.3109/13697137.2013.823539. Epub 2013 Aug 9.
7
[Risk factors and risk reduction of breast cancer].[乳腺癌的风险因素与风险降低]
Med Sci (Paris). 2005 Feb;21(2):175-80. doi: 10.1051/medsci/2005212175.
8
Breast cancer and ovarian cancer genetics.乳腺癌与卵巢癌遗传学
J Long Term Eff Med Implants. 2005;15(5):533-45. doi: 10.1615/jlongtermeffmedimplants.v15.i5.60.
9
Molecular Action and Clinical Relevance of Aromatase Inhibitors.芳香化酶抑制剂的分子作用及临床相关性
Oncologist. 1998;3(2):129-130.
10
Implementing recommendations for the early detection of breast and cervical cancer among low-income women.落实针对低收入女性乳腺癌和宫颈癌早期检测的建议。
MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55.

引用本文的文献

1
Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape.在乳腺癌中应用全基因组和全外显子组测序:综述全景。
Breast Cancer. 2024 Nov;31(6):999-1009. doi: 10.1007/s12282-024-01628-9. Epub 2024 Aug 27.
2
Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review.体育锻炼与乳腺癌的特征:一项叙述性综述
Cancers (Basel). 2023 Jan 3;15(1):324. doi: 10.3390/cancers15010324.
3
Capsanthin-Loaded Micelles: Preparation, Characterization and Evaluation of Cytotoxicity Using MDA-MB-231 Breast Cancer Cell Line.辣椒红素负载的胶束:使用MDA-MB-231乳腺癌细胞系的制备、表征及细胞毒性评估
Food Technol Biotechnol. 2022 Sep;60(3):350-360. doi: 10.17113/ftb.60.03.22.7405.
4
Design and Evaluation of pH Sensitive PEG-Protamine Nanocomplex of Doxorubicin for Treatment of Breast Cancer.用于治疗乳腺癌的阿霉素pH敏感聚乙二醇-鱼精蛋白纳米复合物的设计与评价
Polymers (Basel). 2022 Jun 14;14(12):2403. doi: 10.3390/polym14122403.
5
Chimeric antigen receptor T-cell immunotherapy in breast cancer: development and challenges.嵌合抗原受体T细胞免疫疗法在乳腺癌中的应用:进展与挑战
J Cancer. 2021 Jan 1;12(4):1212-1219. doi: 10.7150/jca.54095. eCollection 2021.
6
New insights into the roles of the and genes in signaling pathways.深入探讨基因和基因在信号通路中的作用。
Ups J Med Sci. 2019 Aug;124(3):149-157. doi: 10.1080/03009734.2019.1623351. Epub 2019 Jul 11.
7
Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study.CYBA基因(-930 A/G和242 C/T)多态性与乳腺癌氧化应激的关联:一项病例对照研究。
PeerJ. 2018 Oct 4;6:e5509. doi: 10.7717/peerj.5509. eCollection 2018.
8
Integrated analysis of dysregulated lncRNA expression in breast cancer cell identified by RNA-seq study.通过RNA测序研究鉴定的乳腺癌细胞中lncRNA表达失调的综合分析。
Noncoding RNA Res. 2016 Sep 21;1(1):35-42. doi: 10.1016/j.ncrna.2016.09.002. eCollection 2016 Oct.
9
Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.利用瑞典AMORIS队列研究数据探讨葡萄糖和脂蛋白生物标志物与乳腺癌严重程度的关系
BMC Cancer. 2017 Apr 4;17(1):246. doi: 10.1186/s12885-017-3232-6.
10
Effect of β-sitosterol against methyl nitrosourea-induced mammary gland carcinoma in albino rats.β-谷甾醇对白化大鼠甲基亚硝基脲诱导的乳腺癌的影响。
BMC Complement Altern Med. 2016 Jul 29;16:260. doi: 10.1186/s12906-016-1243-5.

本文引用的文献

1
Identifying survival associated morphological features of triple negative breast cancer using multiple datasets.利用多个数据集识别三阴性乳腺癌的生存相关形态特征。
J Am Med Inform Assoc. 2013 Jul-Aug;20(4):680-7. doi: 10.1136/amiajnl-2012-001538. Epub 2013 Apr 12.
2
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor.采用抗 EGFR 导向放射免疫治疗联合放射增敏化疗和 PARP 抑制剂治疗三阴性乳腺癌。
J Nucl Med. 2013 Jun;54(6):913-21. doi: 10.2967/jnumed.112.111534. Epub 2013 Apr 5.
3
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.鉴定化疗耐药性三阴性乳腺癌患者的预后相关亚组。
Clin Cancer Res. 2013 May 15;19(10):2723-33. doi: 10.1158/1078-0432.CCR-12-2986. Epub 2013 Apr 2.
4
The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.局部晚期三阴性乳腺癌新辅助含铂化疗的应用:144 例患者的回顾性分析。
Breast Cancer Res Treat. 2013 Apr;138(3):783-94. doi: 10.1007/s10549-013-2497-y. Epub 2013 Mar 31.
5
Therapeutic targets in triple negative breast cancer.三阴性乳腺癌的治疗靶点。
J Clin Pathol. 2013 Jun;66(6):530-42. doi: 10.1136/jclinpath-2012-201361. Epub 2013 Feb 22.
6
Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy.三阴性乳腺癌的现行治疗策略:手术、放疗和化疗的适当结合。
Breast Cancer. 2011 Jul;18(3):165-73. doi: 10.1007/s12282-011-0254-9. Epub 2011 Feb 3.
7
Ageing, hormonal behaviour and cyclin D1 in ductal breast carcinomas.导管性乳腺癌中的衰老、激素行为与细胞周期蛋白D1
Breast. 2006 Feb;15(1):81-9. doi: 10.1016/j.breast.2004.12.008. Epub 2005 Apr 19.
8
Function of nuclear sex hormone receptors in gene regulation.核性激素受体在基因调控中的作用。
Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:4-9. doi: 10.1007/s00280-005-0102-8.
9
Steroid hormone receptor expression in male breast cancer.男性乳腺癌中类固醇激素受体的表达
Eur J Surg Oncol. 2006 Feb;32(1):44-7. doi: 10.1016/j.ejso.2005.09.013. Epub 2005 Nov 2.
10
Prophylaxis approach to a-symptomatic post-menopausal women: breast cancer.无症状绝经后女性乳腺癌的预防方法
Maturitas. 2005 Nov 15;52 Suppl 1:S23-31. doi: 10.1016/j.maturitas.2005.06.015. Epub 2005 Aug 26.